ARS Pharmaceuticals (SPRY) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 247.47 Mn |
| 10 | ARS Pharmaceuticals | 564.10 Mn | 420.25 Mn | 20.81 Mn | 77.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.58 Mn |
| Mar 31, 2026 | 72.20 Mn |
| Dec 31, 2025 | 59.96 Mn |
| Sep 30, 2025 | 74.75 Mn |
| Jun 30, 2025 | 54.31 Mn |
| Mar 31, 2025 | 41.10 Mn |
| Dec 31, 2024 | 35.49 Mn |
| Sep 30, 2024 | 19.28 Mn |
| Jun 30, 2024 | 8.94 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 6.82 Mn |
| Sep 30, 2023 | 14.98 Mn |
| Jun 30, 2023 | 13.31 Mn |
| Mar 31, 2023 | 12.18 Mn |
| Dec 31, 2022 | 10.73 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | -15.76 Mn |
| Sep 30, 2021 | 7.04 Mn |